IBM
IBM
$235.68
+0.85%
International Business Machines Corporation (IBM) is a global technology company that provides a diverse portfolio of software, IT consulting services, and hardware, helping enterprises modernize their technology workflows across 175 countries. As a veteran industry player, IBM differentiates itself through its hybrid cloud and AI offerings, including Red Hat and watsonx, and its deep integration into critical sectors like finance and retail, serving 95% of Fortune 500 companies. The current investor narrative centers on IBM's AI-driven transformation, but recent quarters have been marred by a software spending warning and a significant stock plunge, raising questions about near-term growth sustainability and the pace of AI monetization. The market is debating whether IBM's AI investments will yield long-term value or if the company is losing ground to more agile competitors in the rapidly evolving AI landscape.…
IBM
IBM
$235.68
Related headlines
Investment Opinion: Should I buy IBM Today?
Based on the analysis, IBM is rated a Hold. The consensus recommendation is Buy with an average target price of $244.16, implying a modest 4.2% upside. The thesis is that IBM's forward PE of 17.79x is attractive relative to peers, but the recent profit warning and revenue volatility warrant caution. The stock offers a 2.27% dividend yield and strong free cash flow, but near-term growth challenges limit upside potential.
Sign up to view all
IBM 12-Month Price Forecast
The AI assessment is neutral with medium confidence. IBM's valuation is attractive on a forward basis, and its free cash flow is strong, but the recent profit warning and revenue volatility introduce significant uncertainty. The stock's low beta and dividend yield provide some downside protection, but the lack of consistent growth limits upside potential. I would upgrade to bullish if IBM demonstrates two consecutive quarters of revenue growth above 10% and the forward PE remains below 18x. Conversely, a downgrade to bearish would occur if revenue growth falls below 5% or if the company issues another profit warning.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on IBM's 12-month outlook, with a consensus price target around $244.91 and implied upside of +3.9% versus the current price.
Average Target
$244.91
0 analysts
Implied Upside
+3.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$174 - $350
Analyst target range
IBM is covered by 23 analysts, with a consensus recommendation of 'buy' and a mean rating of 2.12 (where 1 is strong buy and 5 is sell). The average target price is $244.16, implying a 4.2% upside from the current price of $234.32. The distribution includes 10 buy ratings, 8 hold ratings, and 5 sell ratings, indicating a moderately bullish sentiment but with notable caution. The target price range spans from a low of $174.00 to a high of $350.00, with the high target suggesting a 49.4% upside, likely assuming successful AI monetization and margin expansion, while the low target implies a 25.7% downside, reflecting risks of continued revenue deceleration and competitive pressures. Recent ratings actions have been mixed, with JP Morgan upgrading from Neutral to Overweight in June, but HSBC downgrading from Hold to Reduce in July, highlighting the uncertainty around IBM's near-term prospects.
Bulls vs Bears: IBM Investment Factors
IBM presents a mixed picture: strong free cash flow, a discounted forward valuation, and a Buy consensus are countered by a recent profit warning, volatile revenue, and high leverage. The bull case hinges on successful AI monetization and margin expansion, while the bear case centers on growth deceleration and competitive pressures. Currently, the bearish evidence is slightly stronger due to the recent plunge and revenue inconsistency, but the forward PE discount and analyst targets suggest the downside may be limited. The key tension is whether IBM's AI investments will translate into sustained revenue growth or if the company will continue to lose ground to more agile competitors.
Bullish
- Forward PE at 17.8x is a 19% discount to peers: IBM's forward PE of 17.79x is 19.1% below the industry average of 22x, suggesting the market is pricing in lower growth expectations. This discount could narrow if the company delivers on its AI and cloud initiatives, offering upside potential.
- Strong free cash flow of $14.6B TTM: IBM generated $14.58 billion in free cash flow over the trailing twelve months, providing ample liquidity for dividends, debt reduction, and strategic investments. This robust cash generation supports the 2.27% dividend yield and financial flexibility.
- Revenue growth accelerating in Q1 2026: Q1 2026 revenue grew 9.5% YoY to $15.917 billion, up from 8.9% growth in Q1 2025. This acceleration, driven by software and consulting, indicates that IBM's hybrid cloud and AI strategies are gaining traction.
- Analyst consensus is Buy with 4.2% upside: With a mean rating of 2.12 (Buy) and an average target price of $244.16, analysts see modest upside from the current price of $234.32. The high target of $350 implies a 49.4% potential gain, reflecting optimism about AI monetization.
Bearish
- Profit warning triggered 25% stock plunge: In July 2026, IBM issued a software spending warning, causing a 25% drop in the stock price. This event highlights near-term growth concerns and the risk of AI-related spending shifts away from IBM's offerings.
- Revenue growth is volatile and inconsistent: Quarterly revenue growth has ranged from 9.1% to 16.8% YoY over the past four quarters, with Q2 2026 revenue missing. This inconsistency raises questions about the sustainability of IBM's growth trajectory.
- Trailing PE of 26.07x is 18.5% above industry: IBM's trailing PE of 26.07x is 18.5% higher than the industry average of 22x, indicating that the stock is not cheap on a historical basis. This premium may compress if earnings growth disappoints.
- High debt-to-equity ratio of 2.06: IBM's debt-to-equity ratio of 2.06 indicates significant leverage, which could strain financials if interest rates remain elevated. The company's interest expense of $473 million in Q1 2026 adds to fixed costs.
IBM Technical Analysis
IBM's price trend over the past year has been volatile and ultimately negative, with a 1-year price change of -1.18%, underperforming the S&P 500's +20.37% gain. The stock is currently trading at $234.32, which is approximately 70.5% of its 52-week range (low of $199.19, high of $332.46), indicating it is closer to the lower end of its yearly range. This positioning suggests a bearish sentiment, as the stock has failed to sustain its earlier highs and is now in a recovery phase from a significant drawdown, with a max drawdown of -37.5% over the period.
Beta
0.70
0.70x market volatility
Max Drawdown
-37.5%
Largest decline past year
52-Week Range
$199-$332
Price range past year
Annual Return
-1.6%
Cumulative gain past year
| Period | IBM Return | S&P 500 |
|---|---|---|
| 1m | +14.5% | +2.5% |
| 3m | -7.2% | +2.7% |
| 6m | -8.4% | +11.1% |
| 1y | -1.6% | +20.5% |
| ytd | -19.1% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
IBM Fundamental Analysis
IBM's revenue trajectory has been uneven, with Q2 2026 revenue data not available, but Q1 2026 revenue was $15.917 billion, reflecting a 9.5% increase from Q1 2025's $14.541 billion. However, the most recent quarter (Q2 2026) shows a gross profit of $9.907 billion, but revenue is missing, and the company issued a profit warning, indicating potential deceleration. Over the past four quarters, revenue has ranged from $14.541 billion to $19.686 billion, with the highest in Q4 2025, but growth has been inconsistent, with Q3 2025 revenue of $16.331 billion up 9.1% YoY, yet Q2 2025 revenue of $16.977 billion up 16.8% YoY. The software segment is a key driver, contributing $7.052 billion in the latest segment data, while consulting added $5.272 billion, but the overall growth is challenged by AI-related spending shifts.
Quarterly Revenue
$0.0B
2026-06
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
$14.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is IBM Overvalued?
Given IBM's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 26.07x, while the forward PE is 17.79x, indicating that the market expects earnings growth, with the forward multiple implying a 46.6% discount to trailing. This gap suggests optimism about future profitability, likely driven by AI and cloud investments. Compared to the industry average PE of 22x (from valuation data), IBM's trailing PE of 26.07x represents a 18.5% premium, but the forward PE of 17.79x is at a 19.1% discount, suggesting that on a forward basis, IBM is cheaper than its peers, which may be justified by its lower growth prospects relative to high-growth tech companies.
PE
26.1x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 11x~47x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are elevated due to IBM's high debt-to-equity ratio of 2.06, which increases vulnerability to rising interest rates. The company's interest expense of $473 million in Q1 2026 and $478 million in Q4 2025 indicates a significant fixed cost burden. Additionally, revenue concentration in software and consulting, which together account for over 70% of total revenue, exposes IBM to sector-specific downturns. The recent profit warning in Q2 2026, where revenue was not reported, signals potential earnings volatility and could lead to further downward revisions if the trend persists. Free cash flow of $14.58 billion TTM provides a cushion, but it may not be sufficient if growth stalls and debt servicing costs rise.